| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Formela Jean Francois is a Director at Spero Therapeutics, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 8 sells.
Estimated insider holdings value: $12.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 16, 2018 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 6,686 | $25.04 | $167,389.36 | -100% | |
| Mar 20, 2018 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 39,245 | $23.87 | $936,742.63 | -51.7% | |
| Nov 6, 2017 | SPRO Spero Therapeutics, Inc. | Director | Buy | 428,571 | $14.00 | $5,999,994.00 | +21.6% | |
| Jul 11, 2017 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 150,000 | $16.24 | $2,435,440.00 | -1.4% | |
| Mar 10, 2017 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 21,132 | $13.91 | $293,842.63 | -79.3% |